Profilaxis de los accidentes tromboembólicos venosos en cirugía ortopédica y traumatológica

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 381S, 10.1378/chest.08-0656 Shimoyama, 2012, Perioperative risk factors for deep vein thrombosis after total hip arthroplasty or total knee arthroplasty, J Clin Anesth, 24, 531, 10.1016/j.jclinane.2012.02.008 Wells, 1997, Value of assessment of pretest probability of deep-vein thrombosis in clinical management, Lancet, 350, 1795, 10.1016/S0140-6736(97)08140-3 White, 2003, The epidemiology of venous thromboembolism, Circulation, 107, 4I, 10.1161/01.CIR.0000078468.11849.66 Selby, 2012, Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement, Thromb Res, 130, 166, 10.1016/j.thromres.2012.01.013 Warwick, 2007, Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events : findings from the Global Orthopaedic Registry, J Bone Joint Surg [Br], 89, 799, 10.1302/0301-620X.89B6.18844 Todd, 1995, Differences in mortality after fracture of hip: the east Anglian audit, Br Med J, 310, 904, 10.1136/bmj.310.6984.904 Dahl, 2000, Late occurring clinical deep vein thrombosis in joint-operated patients, Acta Orthop Scand, 71, 47, 10.1080/00016470052943883 Arcelus, 2008, Clinical presentation and time-course of postoperative venous thromboembolism: results from the RIETE Registry, Thromb Haemost, 99, 546, 10.1160/TH07-10-0611 New, 2011, Pulmonary thromboembolism, Compend Contin Educ Vet, 33, E1 Hansson, 2000, Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors, Arch Intern Med, 160, 769, 10.1001/archinte.160.6.769 Heit, 2009, Is diabetes mellitus an independent risk factor for venous thromboembolism? A population-based case-control study, Arterioscler Thromb Vasc Biol, 29, 1399, 10.1161/ATVBAHA.109.189290 Goldhaber, 1997, A prospective study of risk factors for pulmonary embolism in women, JAMA, 277, 642, 10.1001/jama.1997.03540320044033 Goldhaber, 1987, Cancer and venous thromboembolism, Arch Intern Med, 147, 216, 10.1001/archinte.1987.00370020036030 Poredos, 2011, Dyslipidemia, statins, and venous thromboembolism, Semin Thromb Hemost, 37, 897, 10.1055/s-0031-1297368 Sharrock, 1991, Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty, J Bone Joint Surg [Am], 73, 502, 10.2106/00004623-199173040-00004 Ageno, 2014, Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis, Arterioscler Thromb Vasc Biol, 34, 2478, 10.1161/ATVBAHA.114.304085 Seligsohn, 2001, Genetic susceptibility to venous thrombosis, N Engl J Med, 344, 1222, 10.1056/NEJM200104193441607 Clagett, 1988, Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis, Ann Surg, 208, 227, 10.1097/00000658-198808000-00016 Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients, Chest, 141, 10.1378/chest.11-2404 Venous thromboembolism: reducing the risk of venous thromboembolism (Deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141 Chee, 2008, Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures, Br J Haematol, 140, 496, 10.1111/j.1365-2141.2007.06968.x Decousus, 2011, Bergmann J-F. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators, Chest, 139, 69, 10.1378/chest.09-3081 Molliex, 2012, Routine preinterventional tests, Ann Fr Anesth Reanim, 31, 752, 10.1016/j.annfar.2012.06.009 Grady-Benson, 1994, Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis. A survey of 110 total hip arthroplasties, Clin Orthop, 307, 130 Vanninen, 1993, Asymptomatic deep venous thrombosis in the calf: accuracy and limitations of ultrasonography as a screening test after total knee arthroplasty, Br J Radiol, 66, 199, 10.1259/0007-1285-66-783-199 Westrich, 1998, Ultrasound screening for deep venous thrombosis after total knee arthroplasty. Two year reassessment, Clin Orthop, 356, 125, 10.1097/00003086-199811000-00018 Grady-Benson, 1994, Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty, J Bone Joint Surg [Am], 76, 1649, 10.2106/00004623-199411000-00008 Atri, 1996, Accuracy of sonography in the evaluation of calf deep vein thrombosis in both postoperative surveillance and symptomatic patients, AJR Am J Roentgenol, 166, 1361, 10.2214/ajr.166.6.8633448 Elias, 2004, Extended lower limb ultrasound for the diagnosis of proximal and distal vein thrombosis in asymptomatic patients after total hip replacement, Eur J Vasc Endovasc Surg, 27, 438, 10.1016/j.ejvs.2003.12.021 Rodgers, 2000, Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials, Br Med J, 321, 1493, 10.1136/bmj.321.7275.1493 Merli, 1987, Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient, Med Clin North Am, 71, 377, 10.1016/S0025-7125(16)30847-1 McKenzie, 1991, Deep venous thrombosis and anaesthesia, Br J Anaesth, 66, 4, 10.1093/bja/66.1.4 Nielsen, 1990, Lower thrombosis risk with epidural blockade in knee arthroplasty, Acta Orthop Scand, 61, 29, 10.3109/17453679008993060 Christopherson, 1993, Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative ischemia randomized anesthesia trial study group, Anesthesiology, 79, 422, 10.1097/00000542-199309000-00004 Leonard, 2001, Does prior administration of enoxaparin influence the effects of levobupivacaine on blood clotting?, Br J Anaesth, 86, 808, 10.1093/bja/86.6.808 Hahnenkamp, 2002, The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation, Anesth Analg, 94, 1441, 10.1213/00000539-200206000-00011 Macfarlane, 2009, Does regional anaesthesia improve outcome after total hip arthroplasty?. A systematic review, Br J Anaesth, 103, 335, 10.1093/bja/aep208 Bagry, 2008, Effect of a continuous peripheral nerve block on the inflammatory response in knee arthroplasty, Reg Anesth Pain Med, 33, 17, 10.1097/00115550-200801000-00004 Estebe, 2011, The pneumatic tourniquet: mechanical, ischaemia-reperfusion and systemic effects, Eur J Anaesthesiol, 28, 404, 10.1097/EJA.0b013e328346d5a9 Kehlet, 2001, Effect of postoperative analgesia on surgical outcome, Br J Anaesth, 87, 62, 10.1093/bja/87.1.62 Chelly, 2008, International normalized ratio and prothrombin time values before the removal of a lumbar plexus catheter in patients receiving warfarin after total hip replacement, Br J Anaesth, 101, 250, 10.1093/bja/aen132 Camporese, 2008, Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial, Ann Intern Med, 149, 73, 10.7326/0003-4819-149-2-200807150-00003 Kakkos, 2016, Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism, Cochrane Database Syst Rev Afshari, 2018, European Guidelines on perioperative venous thromboembolism prophylaxis: executive summary, Eur J Anaesthesiol, 35, 77, 10.1097/EJA.0000000000000729 Turpie, 1986, A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery, N Engl J Med, 315, 925, 10.1056/NEJM198610093151503 Nurmohamed, 1992, Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis, Lancet, 340, 152, 10.1016/0140-6736(92)93223-A Rosencher, 2005, Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study, J Thromb Haemost, 3, 2006, 10.1111/j.1538-7836.2005.01545.x Douketis, 2002, Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes, Arch Intern Med, 162, 1465, 10.1001/archinte.162.13.1465 Samama, 2011, Prévention de la maladie thromboembolique veineuse postopératoire. Actualisation 2011. Texte court, Ann Fr Anesth Reanim, 30, 947, 10.1016/j.annfar.2011.10.008 Turpie, 2003, Steering Committees of the Pentasaccharide Orthopedic Prophylaxis Studies. Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration, Thromb Haemost, 90, 364, 10.1055/s-0037-1613491 Friedman, 2008, Global Orthopaedic Registry Investigators. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty, Curr Med Res Opin, 24, 87, 10.1185/030079907X242746 Fordyce, 2016, On-treatment outcomes in patients with worsening renal function with rivaroxaban compared with WarfarinClinical Perspective, Circulation, 134, 37, 10.1161/CIRCULATIONAHA.116.021890 Unknown, 2014, Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry, Eur Heart J, 35, 1888, 10.1093/eurheartj/eht557 Blech, 2008, The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans, Drug Metab Dispos, 36, 386, 10.1124/dmd.107.019083 Stangier, 2007, The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects, Br J Clin Pharmacol, 64, 292, 10.1111/j.1365-2125.2007.02899.x Stangier, 2005, Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement, J Clin Pharmacol, 45, 555, 10.1177/0091270005274550 Eriksson, 2009, Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development, Clin Pharmacokinet, 48, 1, 10.2165/0003088-200948010-00001 Lang, 2009, In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans, Drug Metab Dispos, 37, 1046, 10.1124/dmd.108.025551 Frost, 2013, Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects, Br J Clin Pharmacol, 75, 476, 10.1111/j.1365-2125.2012.04369.x Kubitza, 2005, Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor, Clin Pharmacol Ther, 78, 412, 10.1016/j.clpt.2005.06.011 Anderson, 2013, Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty, Ann Intern Med, 158, 800, 10.7326/0003-4819-158-11-201306040-00004 1994, Collaborative overview of randomised trials of antiplatelet therapy--III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical, patients. Antiplatelet trialists’ collaboration, Br Med J, 308, 235, 10.1136/bmj.308.6923.235 Anderson, 2018, Aspirin or Rivaroxaban for VTE prophylaxis after hip or knee arthroplasty, N Engl J Med, 378, 699, 10.1056/NEJMoa1712746 Albaladejo P, Godier A, Mismetti P, Roullet S, Steib A et le Groupe d’Interêt en Hémostase Périopératoire. Commentaires et propositions du Groupe d’Intérêt en Hémostase Périopératoire sur les recommandations de la Société Européenne d’Anesthésie : « Europeen Guidelines on perioperative venous thromboembolism prophylaxis » Site de la Société Française d’Anesthésie-Réanimation, 2 juillet 2019. Samama, 2011, Prévention de la maladie thromboembolique veineuse postopératoire. Actualisation 2011, Ann Fr Anesth Reanim, 30, 947, 10.1016/j.annfar.2011.10.008 Chan, 2015, A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal, J Thromb Thrombolysis, 40, 231, 10.1007/s11239-014-1153-7 Colwell, 2006, Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery, J Arthroplasty, 21, 36, 10.1016/j.arth.2005.05.023 Raskob, 2003, Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery, Chest, 124, 379S, 10.1378/chest.124.6_suppl.379S Haas, 2016, The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study, Vasc Health Risk Manag, 12, 209, 10.2147/VHRM.S100293